Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients

Drug and Alcohol Dependence
Andrea K FinlayIngrid A Binswanger

Abstract

Pharmacotherapy - methadone, buprenorphine, or naltrexone - is an evidence-based treatment for opioid use disorder, but little is known about receipt of these medications among veterans involved in the justice system. The current study examines receipt of pharmacotherapy for opioid use disorder among veterans with a history of justice involvement at U.S. Veterans Health Administration (VHA) facilities compared to veterans with no justice involvement. Using national VHA clinical and pharmacy records, we conducted a retrospective cohort study of veterans with an opioid use disorder diagnosis in fiscal year 2012. Using a mixed-effects logistic regression model, we examined receipt of pharmacotherapy in the 1-year period following diagnosis as a function of justice involvement, adjusting for patient and facility characteristics. The 1-year rate of receipt for pharmacotherapy for opioid use disorder was 27% for prison-involved veterans, 34% for jail/court-involved veterans, and 33% for veterans not justice-involved. Compared to veterans not justice-involved, those prison-involved had 0.75 lower adjusted odds (95% confidence interval [CI]: 0.65-0.87) of receiving pharmacotherapy whereas jail/court-involved veterans did not have signi...Continue Reading

References

Jun 1, 1992·Journal of Clinical Epidemiology·R A DeyoM A Ciol
Nov 20, 2008·JAMA : the Journal of the American Medical Association·Herbert D Kleber
May 12, 2009·Substance Abuse Treatment, Prevention, and Policy·Juliana van OlphenMarilyn Barnes
Aug 9, 2011·Journal of Substance Abuse Treatment·Jan GryczynskiJerome H Jaffe
Sep 20, 2011·Social Science Research·Amanda Geller, Marah A Curtis
Jan 24, 2012·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Peter D FriedmannUNKNOWN Mat Working Group Of CJ-Dats
Jan 24, 2012·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Jan GryczynskiRobert P Schwartz
Jan 24, 2012·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Donna M CovielloCharles P O'Brien
May 3, 2012·Psychiatric Services : a Journal of the American Psychiatric Association·Alex H S HarrisJodie A Trafton
Sep 12, 2012·Addiction Science & Clinical Practice·Ingrid A BinswangerJohn F Steiner
Dec 12, 2012·Journal of Substance Abuse Treatment·Harlan MatusowAndrew Rosenblum
Mar 5, 2013·Journal of Addiction Medicine·Sharon M KellyRobert P Schwartz
Mar 20, 2013·Social Psychiatry and Psychiatric Epidemiology·Jack TsaiJames F McGuire
Nov 2, 2013·Psychiatric Services : a Journal of the American Psychiatric Association·Ana R QuiñonesVincent S Fan

❮ Previous
Next ❯

Citations

May 15, 2016·Contemporary Clinical Trials·Ryan D McDonaldJoshua D Lee
Apr 4, 2017·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Avi A Weinbroum
Mar 30, 2018·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Jessica J WyseTravis I Lovejoy
Jan 22, 2020·Substance Abuse Treatment, Prevention, and Policy·Tiffany Champagne-LangabeerJames R Langabeer
Jun 26, 2020·Journal of General Internal Medicine·Andrea K FinlayIngrid A Binswanger
Dec 17, 2020·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Beth M DeRonneErin E Krebs
Dec 6, 2019·Peptides·Richard J Bodnar
Nov 5, 2020·Journal of General Internal Medicine·Wilson M ComptonCarlos Blanco
Aug 23, 2020·Journal of Addiction Medicine·Andrea K FinlayIngrid A Binswanger
Sep 30, 2021·Substance Abuse : Official Publication of the Association for Medical Education and Research in Substance Abuse·Emmeline N TaylorAndrea K Finlay

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.